2-Oxazolidinone → 3-{4-[4-(3,5-Dimethylpyridin-2-yl)piperazine-1-carbonyl]-3-(1,1-dioxo-1,2-thiazinan-2-yl)phenyl}oxazolidin-2-one

Participants

Role	Name	HCID	Charge
Reactant	2-Oxazolidinone	HCID 73949	—
Reactant	[4-Chloro-2-(1,1-dioxo-1,2-thiazinan-2-yl)phenyl][4-(3,5-dimethylpyridin-2-yl)piperazin-1-yl]methanone	HCID 58484702	—
Product	3-{4-[4-(3,5-Dimethylpyridin-2-yl)piperazine-1-carbonyl]-3-(1,1-dioxo-1,2-thiazinan-2-yl)phenyl}oxazolidin-2-one	HCID 46190278	19.8%

Reaction Steps

By reaction and treatment in the same manner as in Example 201 and using [4-chloro-2-(1,1-dioxo-1,2-thiazinan-2-yl)phenyl][4-(3,5-dimethylpyridin-2-yl)piperazin-1-yl]methanone (161.5 mg) described in Preparation Example 128 and oxazolidin-2-one (30.4 mg), the title compound (35.4 mg) was obtained.

Provenance & Evidence

DOI	10.6084/m9.figshare.5104873.v1
Patent number	US08354401B2
Source dataset	uspto-grants-2013_01
ORD ID	ord-2d0d079e413b4cdcbb34fc4231d62e30
Source note	uspto-grants-2013_01